C.MartuccielloS.NoriS
However, many researchers find that a small, light snack 30 to 60 minutes before injection reduces acute nausea
GLP-1 drugs like semaglutide, tirzepatide, and liraglutide mainly cause GI symptoms, nausea, vomiting, diarrhea, constipation, bloating, and can rarely lead to pancreatitis, gallbladder disease, or kidney issues
Another limitation is the lack of large-scale, long-term studies in type 1 diabetes
In a blog, the facility writes that MT2 isn't "currently approved by the FDA." Additionally, West Lake Dermatology says that the compound "cannot be legally marketed or sold as a drug, supplement, or cosmetic product." Further, it isn't "used in standard medical practices." It's "largely unregulated, with no reliable assurance of purity, sterility, or dosing." West Lake Dermatology writes that MT2 began its life as a peptide used for academic purposes